Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005 Jun 28;11(24):3800-2.
doi: 10.3748/wjg.v11.i24.3800.

Utility of fusion CT-PET in the diagnosis of small pancreatic carcinoma

Affiliations
Case Reports

Utility of fusion CT-PET in the diagnosis of small pancreatic carcinoma

Brian Kim-Poh Goh et al. World J Gastroenterol. .

Abstract

Pancreatic carcinoma has a poor prognosis and early detection is essential for potentially curative resection. Despite the wide array of diagnostic tools, preoperative detection of small pancreatic carcinomas remains difficult. We report a case of small pancreatic carcinoma of the head of pancreas with indeterminate findings on US, ERCP, MRI and EUS which was successfully diagnosed via fusion CT-PET. This case illustrates the utility of CT-PET in the diagnosis of patients with small pancreatic carcinoma with equivocal findings on conventional diagnostic modalities.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Whole body and combined fusion CT-PET of the pancreas. A: Whole body CT-PET demonstrating a focus of increased uptake in the pancreatic head (arrowed); B: Although no lesion was seen on CT, anatomical localization was possible with fusion CT-PET to the pancreatic head (arrowed). A CBD stent is seen in situ.
Figure 2
Figure 2
Post-Whipple’s specimen demonstrating a mass in the head of pancreas causing narrowing of the distal CBD (arrowed).

References

    1. Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, Büchler MW. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut. 1995;36:771–777. - PMC - PubMed
    1. Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, et al. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg. 1999;229:729–737; discussion 737-738. - PMC - PubMed
    1. Balci NC, Semelka RC. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Radiol. 2001;38:105–112. - PubMed
    1. Berberat P, Friess H, Kashiwagi M, Beger HG, Büchler MW. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg. 1999;23:882–887. - PubMed
    1. Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg. 2001;234:675–680. - PMC - PubMed

Publication types